Neimeth International Pharmaceuticals Plc has reported a 102 per cent surge in revenue, rising from N2.2bn in 2023 to N4.5bn in 2024.
The Managing Director and Chief Executive Officer of Neimeth, Valentine Okelu, disclosed this at a media parley on Thursday, where he provided insights into the company’s financial performance and strategic direction.
According to him, the pharmaceutical firm recorded a 170 per cent increase in gross profit…
Read the full article here
